Thermosensitive Hydrogel Enables Noninvasive Extracellular Vesicle Therapy for Atopic Dermatitis
Biomaterials Research · 01.01.2026 · 30
DOI: 10.34133/bmr.0368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 18.05.2026. Verfasst von Doil Park und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul …. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science and ICT, South Korea, Incheon National University.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by impaired barrier function and helper T cell 2 (Th2)-dominant immune dysregulation. Subcutaneous administration of mesenchymal-stem-cell-derived extracellular vesicles (MSC-EVs) has shown substantial efficacy in preclinical AD models; however, its clinical utility remains restricted by injection-associated pain and poor patient compliance, necessitating more patient-friendly delivery strategies. Here, we propose a patient-friendly, noninvasive therapeutic strategy using clinical-grade MSC-EVs incorporated into a thermosensitive hyaluronic acid/Pluronic F127 (HP) hydrogel. The optimized HP hydrogel exhibited desirable shear-thinning behavior and tunable sol–gel transition at body temperature, enabling sustained EV release. In a Dermatophagoides farinae -extract-induced AD mouse model, topical application of HP-loaded EVs (HP+EVs) suppressed AD symptoms, epidermal thickening, and mast cell infiltration, demonstrating an efficacy comparable to that of subcutaneous EV injections. Notably, HP+EV treatment down-regulated both Th2 and Th1/pro-inflammatory cytokines, restoring their levels to those in healthy controls. In addition, EVs rapidly penetrated the disrupted skin barrier in AD lesions via surface-protein-dependent mechanisms, as evidenced by the loss of permeability following proteinase K treatment. Furthermore, HP+EV treatment up-regulated barrier proteins and markedly down-regulated oxidative stress markers. This study demonstrates a major advancement in EV-based therapeutics, providing a promising noninvasive formulation for the treatment of AD.
Autor:innen und Institutionen
- Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul 06355, Republic of Korea.
- Department of Biomedical & Robotics Engineering, College of Engineering, Incheon National University, Incheon 22012, Republic of Korea.
- S&E bio, Inc., Seoul 06351, Republic of Korea.
- Department of Bioengineering and Nano-Bioengineering, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.
- Research Center for Bio Materials & Process Development, Incheon National University, Incheon 22012, Republic of Korea.
- Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
ORCID-Profile: Jae Min Cha
Förderung
- Ministry of Science and ICT, South Korea
- Incheon National University
Zitieren
APA
Park, D., Jeon, M., Kim, J., Kim, J. E., Kim, Y., Park, K. M., Kim, E. H., Cha, J. M., & Bang, O. Y. (2026). Thermosensitive Hydrogel Enables Noninvasive Extracellular Vesicle Therapy for Atopic Dermatitis. Biomaterials Research, 30. https://doi.org/10.34133/bmr.0368
Vancouver
Park D, Jeon M, Kim J, Kim JE, Kim Y, Park KM, et al. Thermosensitive Hydrogel Enables Noninvasive Extracellular Vesicle Therapy for Atopic Dermatitis. Biomaterials Research. 2026;30. doi:10.34133/bmr.0368
BibTeX
@article{Park2026,
author = {Park, Doil and Jeon, Mingyu and Kim, Jooho and Kim, Ji Eun and Kim, Yeonjeong and Park, Kyung Min and Kim, Eun Hee and Cha, Jae Min and Bang, Oh Young},
title = {Thermosensitive Hydrogel Enables Noninvasive Extracellular Vesicle Therapy for Atopic Dermatitis},
journal = {Biomaterials Research},
year = {2026},
volume = {30},
doi = {10.34133/bmr.0368}
}
EUVIMED